Janssen hands back rights to imetelstat by Selina McKee | Sep 27, 2018 | News | 0 Janssen Biotech has decided to terminate a collaboration and license agreement with Geron Corp for experimental cancer drug imetelstat. Read More
Theravance Ireland signs deal with Janssen Biotech by Selina McKee | Feb 8, 2018 | News | 0 Theravance Biopharma Ireland has signed a global co-development and commercialisation deal with Janssen Biotech focusing on new treatments for inflammatory intestinal conditions, including ulcerative colitis and Crohn’s disease. Read More